SMTL ID : 3m42.1

Crystal structure of MAPKAP kinase 2 (MK2) complexed with a tetracyclic ATP site inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.68 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 4 residues within 4Å: Chain A: S.68, Q.69, C.70, I.73 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:S.68, A:C.70, A:I.73, H2O.1

1 x HGF: 2-[5-(2-methoxyethoxy)pyridin-3-yl]-8,9,10,11-tetrahydro-7H-pyrido[3',4':4,5]pyrrolo[2,3-f]isoquinolin-7-one(Non-covalent)

HGF.2: 17 residues within 4Å: Chain A: L.26, L.28, G.29, V.34, A.47, K.49, V.74, M.94, E.95, C.96, L.97, G.100, E.101, N.147, L.149, T.162, D.163 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.26, A:V.34, A:V.74, A:L.149, A:T.162 Hydrogen bonds: A:K.49, A:L.97, A:D.163 Water bridges: A:L.26, A:N.147, A:D.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Revesz, L. et al., Novel pyrrolo[2,3-f]isoquinoline based MAPKAP-K2 (MK2) inhibitors with potent in vitro and in vivo activity. To be Published

Release Date

2011-03-23

Peptides

MAP kinase-activated protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MAP kinase-activated protein kinase 2

Related Entries With Identical Sequence